IMDX compared with LCTX: revenue, margins and what each company keeps, and the suppliers and customers both name

IMDXInsight Molecular Diagnostics Inc.

Mkt capRevenueRevenue

LCTXLineage Cell Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

IMDXInsight Molecular Diagnostics Inc.

LCTXLineage Cell Therapeutics, Inc.

Price

Mkt cap

Revenue

Co-movers

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

IMDXInsight Molecular Diagnostics Inc.

2.90▼−2.03%

Mkt cap$96.9MRevenue$239,000Q2 FY26Revenue$4MFY25

LCTXLineage Cell Therapeutics, Inc.

1.00▲+0.42%

Regular sessionNov 2 '26

Mkt cap$252.9MRevenue$1MQ2 FY26Revenue$15MFY25

Compare

Regular sessionNov 2 '26

IMDXInsight Molecular Diagnostics Inc.

LCTXLineage Cell Therapeutics, Inc.

2.90▼−2.03%

Price

1.00▲+0.42%

$96.9M

Mkt cap

$252.9M

Q2 FY26$239,000

Revenue

$1MQ2 FY26

FY25$4M

Revenue

$15MFY25

IMDX2.90▼−2.03%vsLCTX1.00▲+0.42%Regular sessionNov 2 '26

daily closesMethod ›

Moved together

IMDXwithLCTX

No shared trading history for IMDX and LCTX.

Shared co-movers: not yet measured (IMDX, LCTX).

IMDX, solidLCTX, hatchedr = correlationBar = r to r 0.75Source: daily closes